Proteins

Items 291-300 of 708

per page
Set Descending Direction
  1. Erythrina cristagalli lectin (ECL, ECA), Fluorescein
    VC-FL-1141
    VC-FL-1141-M0055 mg
    CHF 293.00
  2. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  3. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  4. Fc (human) IgG1 Control (rec.)
    AG-35B-0007
    AG-35B-0007-C05050 µg
    CHF 170.00
    AG-35B-0007-20502 x 50 µg
    CHF 290.00
    AG-35B-0007-C500500 µg
    CHF 720.00
    AG-35B-0007-M0011 mg
    CHF 1'270.00
  5. Fc (human) IgG1 Control (rec.)
    CHI-HF-210IG1
    CHI-HF-210IG1-C100100 µg
    CHF 390.00
  6. Fc (human) IgG1 Control (rec.) (non-lytic)
    AG-35B-0016
    AG-35B-0016-C01010 µg
    CHF 340.00
    AG-35B-0016-30103 x 10 µg
    CHF 680.00
    AG-35B-0016-C100100 µg
    CHF 1'360.00
  7. Fc (human) IgG1 Control (rec.) (non-lytic)
    CHI-HF-220IG1
    CHI-HF-220IG1-C100100 µg
    CHF 390.00
  8. Fc (human) IgG2 Control (rec.)
    AG-35B-0009
    AG-35B-0009-C05050 µg
    CHF 200.00
    AG-35B-0009-20502 x 50 µg
    CHF 350.00
  9. Fc (human) IgG4 Control (rec.)
    CHI-HF-210IG4
    CHI-HF-210IG4-C100100 µg
    CHF 390.00
  10. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper

Items 291-300 of 708

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.